Skip to content

<

What Is Batten Disease?
Annual Conference
Support
Research
Advocacy
Memorials
About
Contact
News
Search for:

What Is Batten Disease?
Annual Conference
Support
Research
Advocacy
Memorials
About
Contact
News
Search for:

What Is Batten Disease?
Annual Conference
Support
Research
Advocacy
Memorials
About
Contact
News

CLN1 CTA Community Letter_v3_121621_FINAL

Home
Taysha Gene Therapies has announced an important milestone for the Queen’s University clinical trial for TSHA-118, a CLN1 disease clinical trial funded by Taysha Gene Therapies. Please read the community letter here
CLN1 CTA Community Letter_v3_121621_FINAL

CLN1 CTA Community Letter_v3_121621_FINAL

CLN1 CTA Community Letter_v3_121621_FINAL

By Morgan Deboth|2021-12-16T18:01:17-05:00December 16th, 2021|Comments Off on CLN1 CTA Community Letter_v3_121621_FINAL

Share This Story, Choose Your Platform.

Facebook X Pinterest Email

CLN1 CTA Community Letter_v3_121621_FINAL

PO Box 30049
Gahanna, OH 43230
(800) 448-4570

Copyright © 2024 Batten Disease Support, Research, & Advocacy Foundation. | All Rights Reserved | Privacy Policy | Sitemap | Terms & Conditions

entT